Vera Therapeutics (VERA) Assets Average (2021 - 2026)
Vera Therapeutics' (VERA) quarterly Assets Average came in at $678.2 million in Q1 2026, up 7.16% YoY from $632.9 million in Q1 2025, and up 8.32% on a QoQ basis from $626.1 million in Q4 2025.
Vera Therapeutics (VERA) Assets Average (2021 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 6 years of Assets Average data on file, last reported at $678.2 million in Q1 2026.
- Quarterly Assets Average rose 7.16% year-over-year to $678.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $678.2 million (up 7.16% YoY) and the FY2025 annual result came in at $695.2 million, up 67.27% from the prior year.
- Assets Average advanced to $678.2 million in Q1 2026, from $626.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $678.2 million in Q1 2026 to a low of $124.4 million in Q1 2022.
- A 5-year average of $351.0 million and a median of $297.5 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average surged 191.67% — and 2026, when it advanced 7.16%.
- Tracing VERA's Assets Average over 5 years: stood at $131.4 million in 2022, then surged by 33.62% to $175.6 million in 2023, then surged by 191.67% to $512.1 million in 2024, then rose by 22.26% to $626.1 million in 2025, then advanced by 8.32% to $678.2 million in 2026.
- The last three Assets Average figures came in at $678.2 million (Q1 2026), $626.1 million (Q4 2025), and $548.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 577.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 577.36 Mn |
| Mar 31, 2026 | 678.24 Mn |
| Dec 31, 2025 | 626.12 Mn |
| Sep 30, 2025 | 548.02 Mn |
| Jun 30, 2025 | 594.35 Mn |
| Mar 31, 2025 | 632.92 Mn |
| Dec 31, 2024 | 512.12 Mn |
| Sep 30, 2024 | 382.93 Mn |
| Jun 30, 2024 | 408.32 Mn |
| Mar 31, 2024 | 297.45 Mn |
| Dec 31, 2023 | 175.58 Mn |
| Sep 30, 2023 | 185.40 Mn |
| Jun 30, 2023 | 202.39 Mn |
| Mar 31, 2023 | 170.52 Mn |
| Dec 31, 2022 | 131.40 Mn |
| Sep 30, 2022 | 140.08 Mn |
| Jun 30, 2022 | 156.88 Mn |
| Mar 31, 2022 | 124.36 Mn |
| Dec 31, 2021 | 87.46 Mn |
| Sep 30, 2021 | 94.41 Mn |